PATENT CLAIM ANALYSIS

Application Number: 15781825
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["435", "239000"]

Abstract:
Described herein are processes for purifying infectious Zika virus particles and uses of protamine in such processes.

Claim (Index 12):
The process of any one of  claims 3  to  11 , wherein the Zika virus is propagated in a cell line selected from the group consisting of an EB66 cell line, a Vero cell line, a Vero-\u03b1His cell line, a HeLa cell line, a HeLa\u2014S3 cell line, a 293 cell line, a PC12 cell line, a CHO cell line, a 3T3 cell line, a PerC6 cell line, a MDSK cell line, a chicken embryonic fibroblast cell line, a duck cell line, and a diploid avian cell line.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 94.0
- Lexical Diversity: 1.05882
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15781959', '16062245', '16063007', '15212804', '15897488']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7248218282939811
- 35 USC 102 Novelty (BERT): 0.6201467240979043
- Combined Prediction Score: 0.7143543178743734
- Mean Citation Score: 445.52125
- Max Citation Score: 651.8094
- Similarity Product: 504.17252827677726

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test